These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2847282)

  • 1. Interactions of cytomegalovirus with the human immune system.
    Rook AH
    Rev Infect Dis; 1988; 10 Suppl 3():S460-7. PubMed ID: 2847282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune reaction to human cytomegalovirus].
    Ito M
    Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
    Rook AH; Masur H; Lane HC; Frederick W; Kasahara T; Macher AM; Djeu JY; Manischewitz JF; Jackson L; Fauci AS; Quinnan GV
    J Clin Invest; 1983 Jul; 72(1):398-403. PubMed ID: 6308051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
    Borysiewicz LK; Hickling JK; Graham S; Sinclair J; Cranage MP; Smith GL; Sissons JG
    J Exp Med; 1988 Sep; 168(3):919-31. PubMed ID: 2844952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
    Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity.
    Schrier RD; Oldstone MB
    J Virol; 1986 Jul; 59(1):127-31. PubMed ID: 3012111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.
    Di Bona D; Accardi G; Aiello A; Bilancia M; Candore G; Colomba C; Caruso C; Duro G; Gambino CM; Macchia L; Pandey JP
    Immunology; 2018 Apr; 153(4):523-531. PubMed ID: 29067686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of serum and CTL on focal growth of human cytomegalovirus.
    Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
    J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus immunity and immune evasion.
    Jackson SE; Mason GM; Wills MR
    Virus Res; 2011 May; 157(2):151-60. PubMed ID: 21056604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy of HCMV infection.
    Kapp M; Tan SM; Einsele H; Grigoleit G
    Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome.
    Rook AH; Manischewitz JF; Frederick WR; Epstein JS; Jackson L; Gelmann E; Steis R; Masur H; Quinnan GV
    J Infect Dis; 1985 Sep; 152(3):627-30. PubMed ID: 2993445
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
    Boppana SB; Britt WJ
    Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI; Han H; Kim CC; Kim TG
    J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation.
    Zdziarski P
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
    El Baba R; Herbein G
    Front Immunol; 2021; 12():730765. PubMed ID: 34566995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.